Nantahala Capital Management
Latest statistics and disclosures from Nantahala Capital Management's latest quarterly 13F-HR filing:
- Top 5 stock holdings are IWM, PTON, HGV, HLF, TBBK, and represent 34.14% of Nantahala Capital Management's stock portfolio.
- Added to shares of these 10 stocks: QTUM (+$37M), NBIX (+$34M), PRAX (+$34M), KRYS (+$32M), SNAP (+$22M), ADMA (+$20M), XBI (+$16M), VOR (+$16M), PLNT (+$15M), Amanat Acquisition Corp (+$12M).
- Started 25 new stock positions in Jatt Ii Acquisition Corp, IMUX, VOR, ALXO, ADMA, IVA, CATX, PLNT, SNAP, QTUM.
- Reduced shares in these 10 stocks: Soleno Therapeutics (-$84M), QURE (-$65M), PTON (-$50M), TEVA (-$45M), ESTA (-$43M), HGV (-$25M), TNGX (-$23M), AVR (-$21M), ALGN (-$17M), IWM (-$15M).
- Sold out of its positions in GRCE, ACHV, ALGN, Assertio Holdings, CZR, Centessa Pharmaceuticals, CGON, COGT, CRIS, DNTH. IRON, Immunic, KOS, NNBR, PEPG, RVMD, SNTI, SVC, Soleno Therapeutics, SLDB, TEVA, UPB, XNCR, PERFF.
- Nantahala Capital Management was a net seller of stock by $-196M.
- Nantahala Capital Management has $3.0B in assets under management (AUM), dropping by 10.59%.
- Central Index Key (CIK): 0001472322
Tip: Access up to 7 years of quarterly data
Positions held by Nantahala Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Nantahala Capital Management
Nantahala Capital Management holds 138 positions in its portfolio as reported in the June 2026 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Ishares Tr Russell 2000 Etf Put Option (IWM) | 20.0 | $601M | -2% | 2.0M | 300.45 |
|
| Peloton Interactive Cl A Com (PTON) | 4.2 | $127M | -28% | 22M | 5.91 |
|
| Hilton Grand Vacations (HGV) | 3.7 | $110M | -18% | 2.1M | 52.37 |
|
| Herbalife Com Shs (HLF) | 3.4 | $101M | +10% | 7.7M | 13.15 |
|
| Ban (TBBK) | 2.8 | $86M | -9% | 1.4M | 62.64 |
|
| Viatris Call Option (VTRS) | 2.6 | $79M | 5.0M | 15.88 |
|
|
| Edwards Lifesciences Put Option (EW) | 2.4 | $72M | 800k | 90.46 |
|
|
| Uniqure Nv SHS (QURE) | 2.2 | $65M | -50% | 1.4M | 46.06 |
|
| Spdr Series Trust St Str Sp Biot Put Option (XBI) | 2.1 | $63M | +33% | 400k | 158.25 |
|
| Bioventus Com Cl A (BVS) | 1.9 | $57M | 6.0M | 9.44 |
|
|
| Savara (SVRA) | 1.4 | $43M | -5% | 7.0M | 6.16 |
|
| Eton Pharmaceuticals (ETON) | 1.4 | $43M | 1.2M | 36.20 |
|
|
| Amneal Pharmaceuticals Com Stk Cl A (AMRX) | 1.3 | $39M | -20% | 2.3M | 17.31 |
|
| Evolus (EOLS) | 1.3 | $39M | -12% | 5.6M | 6.94 |
|
| Abeona Therapeutics Com New (ABEO) | 1.3 | $38M | +2% | 6.2M | 6.18 |
|
| Etf Ser Solutions Defia Quant Etf Put Option (QTUM) | 1.2 | $37M | NEW | 223k | 165.38 |
|
| Fox Factory Hldg (FOXF) | 1.2 | $36M | -7% | 2.1M | 16.95 |
|
| Camping World Hldgs Cl A (CWH) | 1.2 | $35M | -13% | 4.6M | 7.63 |
|
| Avalo Therapeutics Com New (AVTX) | 1.1 | $34M | +50% | 1.9M | 18.48 |
|
| Lb Pharmaceuticals Com Shs (LBRX) | 1.1 | $34M | 1.1M | 32.45 |
|
|
| Neurocrine Biosciences Call Option (NBIX) | 1.1 | $34M | NEW | 200k | 168.53 |
|
| Praxis Precision Medicines I Com New Put Option (PRAX) | 1.1 | $34M | NEW | 100k | 334.79 |
|
| Anteris Technologies Global (AVR) | 1.1 | $33M | -38% | 3.4M | 9.85 |
|
| Ridenow Group Com Cl B (RDNW) | 1.1 | $33M | 5.0M | 6.66 |
|
|
| Krystal Biotech Put Option (KRYS) | 1.1 | $32M | NEW | 85k | 371.67 |
|
| Establishment Labs Holdings Ord (ESTA) | 1.0 | $29M | -59% | 336k | 85.81 |
|
| Xtant Med Hldgs Com New (XTNT) | 1.0 | $29M | 68M | 0.42 |
|
|
| Jack in the Box (JACK) | 0.9 | $27M | +12% | 1.7M | 15.81 |
|
| Gogo (GOGO) | 0.9 | $27M | -2% | 8.7M | 3.10 |
|
| Imax Corp Cad (IMAX) | 0.9 | $26M | +27% | 658k | 39.86 |
|
| Zevra Therapeutics Com New (ZVRA) | 0.9 | $26M | -28% | 1.8M | 14.34 |
|
| Regeneron Pharmaceuticals Call Option (REGN) | 0.8 | $25M | 40k | 623.54 |
|
|
| Titan Machinery (TITN) | 0.8 | $24M | -9% | 1.1M | 21.12 |
|
| Rmr Group Cl A (RMR) | 0.8 | $24M | 1.1M | 20.53 |
|
|
| Fossil (FOSL) | 0.8 | $23M | 5.5M | 4.14 |
|
|
| Snap Cl A (SNAP) | 0.7 | $22M | NEW | 5.0M | 4.44 |
|
| Mineralys Therapeutics (MLYS) | 0.7 | $22M | -8% | 821k | 26.98 |
|
| Aura Biosciences (AURA) | 0.7 | $21M | +39% | 3.0M | 7.10 |
|
| Agomab Therapeutics Nv Sponsored Ads (AGMB) | 0.7 | $20M | +30% | 1.6M | 12.98 |
|
| Fulcrum Therapeutics (FULC) | 0.7 | $20M | +79% | 5.5M | 3.66 |
|
| Benitec Biopharma Com New (BNTC) | 0.7 | $20M | +3% | 1.5M | 13.38 |
|
| Adma Biologics (ADMA) | 0.7 | $20M | NEW | 2.4M | 8.37 |
|
| BioCryst Pharmaceuticals (BCRX) | 0.6 | $19M | -4% | 1.9M | 10.00 |
|
| MiMedx (MDXG) | 0.6 | $18M | +40% | 4.8M | 3.85 |
|
| Abivax Sa Sponsored Ads (ABVX) | 0.6 | $18M | -2% | 134k | 133.26 |
|
| USANA Health Sciences (USNA) | 0.6 | $17M | 810k | 21.35 |
|
|
| Chime Finl Com Shs Cl A (CHYM) | 0.5 | $16M | -3% | 772k | 20.48 |
|
| Monte Rosa Therapeutics (GLUE) | 0.5 | $16M | 652k | 24.20 |
|
|
| Tango Therapeutics (TNGX) | 0.5 | $16M | -59% | 501k | 31.26 |
|
| Geron Corporation (GERN) | 0.5 | $16M | +8% | 12M | 1.28 |
|
| Vor Biopharma Com New (VOR) | 0.5 | $16M | NEW | 845k | 18.41 |
|
| Keros Therapeutics (KROS) | 0.5 | $15M | +3% | 1.4M | 10.70 |
|
| Vaxcyte (PCVX) | 0.5 | $15M | -6% | 257k | 58.13 |
|
| Silence Therapeutics Ads (SLN) | 0.5 | $15M | -37% | 1.3M | 10.98 |
|
| Apyx Medical Corporation (APYX) | 0.5 | $15M | -4% | 3.3M | 4.49 |
|
| Jefferson Capital (JCAP) | 0.5 | $15M | 750k | 19.47 |
|
|
| Planet Fitness Master Issuer Cl A (PLNT) | 0.5 | $15M | NEW | 279k | 52.17 |
|
| Rh (RH) | 0.5 | $14M | -19% | 87k | 164.73 |
|
| Verastem Com New (VSTM) | 0.5 | $14M | 3.6M | 3.82 |
|
|
| Lawson Products (DSGR) | 0.5 | $14M | 495k | 27.35 |
|
|
| Rayonier Advanced Matls (RYAM) | 0.4 | $13M | +6% | 1.7M | 7.86 |
|
| Helix Acquisition Corp Iii Usd Cl A Ord Shs (HLXC) | 0.4 | $13M | 1.3M | 10.64 |
|
|
| Adc Therapeutics Sa SHS (ADCT) | 0.4 | $13M | +120% | 12M | 1.07 |
|
| Ocuphire Pharma (IRD) | 0.4 | $13M | +82% | 3.1M | 4.11 |
|
| Janux Therapeutics (JANX) | 0.4 | $12M | 810k | 15.36 |
|
|
| Amanat Acquisition Corp Cl A Ord | 0.4 | $12M | NEW | 1.2M | 10.16 |
|
| Inspire Med Sys (INSP) | 0.4 | $12M | NEW | 270k | 44.61 |
|
| 1 800 Flowers Cl A (FLWS) | 0.4 | $12M | 3.4M | 3.48 |
|
|
| X4 Pharmaceuticals Com New (XFOR) | 0.4 | $11M | 2.4M | 4.67 |
|
|
| Integer Hldgs (ITGR) | 0.3 | $10M | -35% | 111k | 93.45 |
|
| Inventiva Sa Ads (IVA) | 0.3 | $10M | NEW | 2.7M | 3.78 |
|
| Industrial Logistics Pptys T Com Shs Ben Int (ILPT) | 0.3 | $9.9M | -33% | 1.1M | 8.87 |
|
| Duolingo Cl A Com (DUOL) | 0.3 | $9.6M | -16% | 84k | 115.02 |
|
| Reservoir Media (RSVR) | 0.3 | $9.3M | 941k | 9.89 |
|
|
| Fractyl Health (GUTS) | 0.3 | $9.0M | -15% | 11M | 0.79 |
|
| Dhi (DHX) | 0.3 | $8.8M | 2.4M | 3.71 |
|
|
| Amylyx Pharmaceuticals (AMLX) | 0.3 | $8.7M | -9% | 487k | 17.96 |
|
| Korro Bio (KRRO) | 0.3 | $8.7M | 660k | 13.18 |
|
|
| Alector (ALEC) | 0.3 | $8.7M | +53% | 4.3M | 2.01 |
|
| Noodles & Co Cl A New (NDLS) | 0.3 | $8.3M | 554k | 14.95 |
|
|
| Codexis (CDXS) | 0.3 | $8.2M | -12% | 3.6M | 2.26 |
|
| Perspective Therapeutics Com New (CATX) | 0.3 | $7.9M | NEW | 2.3M | 3.41 |
|
| Irenic Acquisition Corp Unit 04/10/2031 | 0.3 | $7.6M | NEW | 750k | 10.16 |
|
| Damora Therapeutics Com New (DMRA) | 0.2 | $7.2M | 278k | 26.01 |
|
|
| Viemed Healthcare (VMD) | 0.2 | $7.2M | -28% | 632k | 11.40 |
|
| Unicycive Therapeutics Com New (UNCY) | 0.2 | $6.6M | +49% | 1.4M | 4.69 |
|
| Traeger Com New (COOK) | 0.2 | $6.5M | -19% | 83k | 78.83 |
|
| Forrester Research (FORR) | 0.2 | $6.4M | +9% | 763k | 8.41 |
|
| Lexeo Therapeutics (LXEO) | 0.2 | $6.1M | +8% | 1.3M | 4.66 |
|
| Envoy Medical Cl A (COCH) | 0.2 | $6.0M | 7.7M | 0.78 |
|
|
| Eloxx Pharmaceuticals Com New | 0.2 | $5.6M | NEW | 400k | 13.88 |
|
| Inhibikase Therapeutics Com New (IKT) | 0.2 | $5.5M | 2.7M | 2.03 |
|
|
| First Tracks Biotherapeutics Ord Shs (TRAX) | 0.2 | $5.0M | NEW | 250k | 20.12 |
|
| Mara Holdings Note3/0 (Principal) | 0.2 | $5.0M | 5.0M | 1.00 |
|
|
| Hain Celestial (HAIN) | 0.2 | $4.8M | 8.5M | 0.56 |
|
|
| Alta Equipment Group Common Stock (ALTG) | 0.2 | $4.7M | -22% | 725k | 6.47 |
|
| Orthopediatrics Corp. (KIDS) | 0.2 | $4.6M | +21% | 242k | 19.13 |
|
| Altimmune Com New (ALT) | 0.2 | $4.6M | NEW | 1.5M | 3.04 |
|
| Trisalus Life Sciences (TLSI) | 0.2 | $4.6M | -51% | 1.0M | 4.55 |
|
| Tela Bio (TELA) | 0.1 | $4.4M | 5.9M | 0.75 |
|
|
| One Group Hospitality In (STKS) | 0.1 | $4.3M | 2.1M | 2.01 |
|
|
| Dariohealth Corp (DRIO) | 0.1 | $4.0M | 611k | 6.60 |
|
|
| Immunic Com New (IMUX) | 0.1 | $3.9M | NEW | 251k | 15.37 |
|
| Zai Lab Adr (ZLAB) | 0.1 | $3.8M | NEW | 200k | 19.00 |
|
| Talphera Com New (TLPH) | 0.1 | $3.6M | 3.5M | 1.03 |
|
|
| Venu Hldg Corp (VENU) | 0.1 | $3.5M | -24% | 1.5M | 2.23 |
|
| Payoneer Global (PAYO) | 0.1 | $3.4M | 484k | 7.12 |
|
|
| Elutia Cl A Com (ELUT) | 0.1 | $3.1M | 3.2M | 0.98 |
|
|
| Kailera Therapeutics Common Stock | 0.1 | $3.1M | NEW | 140k | 22.03 |
|
| Rallybio Corp (RLYB) | 0.1 | $3.0M | -37% | 188k | 16.00 |
|
| Artiva Biotherapeutics (ARTV) | 0.1 | $2.9M | NEW | 300k | 9.70 |
|
| Destination Xl (DXLG) | 0.1 | $2.8M | 4.1M | 0.67 |
|
|
| Editas Medicine (EDIT) | 0.1 | $2.8M | NEW | 853k | 3.24 |
|
| eHealth (EHTH) | 0.1 | $2.6M | 1.8M | 1.49 |
|
|
| Jatt Ii Acquisition Corp Ord Shs | 0.1 | $2.6M | NEW | 225k | 11.36 |
|
| Arvinas Ord (ARVN) | 0.1 | $2.5M | 300k | 8.31 |
|
|
| Reading Intl Cl A (RDI) | 0.1 | $2.5M | 1.9M | 1.28 |
|
|
| Inspiremd (NSPR) | 0.1 | $2.4M | 3.4M | 0.70 |
|
|
| Aytu Biopharma (AYTU) | 0.1 | $2.3M | 1.1M | 2.15 |
|
|
| Akebia Therapeutics (AKBA) | 0.1 | $2.3M | 2.0M | 1.14 |
|
|
| Scully Royalty Com Shs (SRL) | 0.1 | $2.3M | 368k | 6.12 |
|
|
| Entrada Therapeutics (TRDA) | 0.1 | $2.2M | +88% | 301k | 7.36 |
|
| Gaia Cl A (GAIA) | 0.1 | $1.9M | 915k | 2.10 |
|
|
| America's Car-Mart (CRMT) | 0.1 | $1.8M | 645k | 2.79 |
|
|
| Alx Oncology Hldgs (ALXO) | 0.1 | $1.6M | NEW | 750k | 2.07 |
|
| Precision Optics Corp Inc Ma Com New (POCI) | 0.0 | $1.4M | 280k | 5.10 |
|
|
| BRC Com Cl A (BRCC) | 0.0 | $1.4M | -52% | 1.3M | 1.11 |
|
| Vyne Therapeutics (VYNE) | 0.0 | $1.3M | 2.0M | 0.65 |
|
|
| Altisource Portfolio Solutio *w Exp 04/30/203 (ASPSW) | 0.0 | $991k | 2.5M | 0.40 |
|
|
| Acme United Corporation (ACU) | 0.0 | $975k | 20k | 47.72 |
|
|
| Perfect Corp Cl A Ord Shs (PERF) | 0.0 | $969k | 584k | 1.66 |
|
|
| Altisource Portfolio Solutio *w Exp 04/02/202 (ASPSZ) | 0.0 | $694k | 2.5M | 0.28 |
|
|
| Cellectar Biosciences Com New (CLRB) | 0.0 | $612k | NEW | 220k | 2.78 |
|
| Spar (SGRP) | 0.0 | $546k | 661k | 0.83 |
|
|
| Azitra Com New (AZTR) | 0.0 | $371k | NEW | 2.2M | 0.17 |
|
| Biomx Com New (PHGE) | 0.0 | $215k | +453% | 635k | 0.34 |
|
| Aprea Therapeutics Com New (APRE) | 0.0 | $165k | 206k | 0.80 |
|
|
| Guardforce Ai *w Exp 10/01/202 (GFAIW) | 0.0 | $5.4k | 154k | 0.04 |
|
Past Filings by Nantahala Capital Management
SEC 13F filings are viewable for Nantahala Capital Management going back to 2011
- Nantahala Capital Management 2026 Q2 filed Aug. 14, 2026
- Nantahala Capital Management 2026 Q1 filed May 15, 2026
- Nantahala Capital Management 2025 Q4 filed Feb. 13, 2026
- Nantahala Capital Management 2025 Q3 filed Nov. 14, 2025
- Nantahala Capital Management 2025 Q2 filed Aug. 14, 2025
- Nantahala Capital Management 2025 Q1 filed May 15, 2025
- Nantahala Capital Management 2024 Q4 filed Feb. 14, 2025
- Nantahala Capital Management 2024 Q3 filed Nov. 14, 2024
- Nantahala Capital Management 2024 Q2 amended filed Aug. 20, 2024
- Nantahala Capital Management 2024 Q2 filed Aug. 14, 2024
- Nantahala Capital Management 2024 Q1 filed May 15, 2024
- Nantahala Capital Management 2023 Q4 amended filed Feb. 15, 2024
- Nantahala Capital Management 2023 Q4 filed Feb. 14, 2024
- Nantahala Capital Management 2023 Q3 filed Nov. 14, 2023
- Nantahala Capital Management 2023 Q2 filed Aug. 14, 2023
- Nantahala Capital Management 2023 Q1 filed May 15, 2023